Lawmakers want lower list prices, but insurers are at fault for mismanaging plans. An unlikely bipartisan consensus has formed to blame pharmaceutical companies for high prescription-drug prices. Democrat Elijah Cummings, chairman of the House Oversight and Reform Committee, held hearings this month on drug companies’ pricing practices,